SKI Market

Indian Indices

Nifty

26,186.45 152.70
(0.59%)

Sensex

85,712.37 447.05
( 0.52%)

Bank Nifty

59,777.20 488.50
( 0.82%)

Nifty IT

38,703.65 343.40
( 0.90%)

Global Indices

Nasdaq

47,981.01 109.07
(0.23%)

Dow Jones

6,892.33 14.21
(0.21%)

Hang Seng

50,440.45 -587.97
(-1.15%)

Nikkei 225

9,667.01 -43.86
(-0.45%)

Forex

USD-INR

89.99 -0.14
(-0.16%)

EUR-INR

104.92 -0.11
(-0.11%)

GBP-INR

120.05 0.29
(0.24%)

JPY-INR

0.58 0.00
(0.11%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

38.82

766.73

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.23

Back

mahindra & mahindra ltd

CL Educate Ltd - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.

Sep 23,2025

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on September 22 2025 for Satya Narayanan R & Gautam Puri

26,186.45 152.70 (0.59%)

85,712.37 447.05 ( 0.52%)

59,777.20 488.50 ( 0.82%)

38,703.65 343.40 ( 0.90%)

47,981.01 109.07 (0.23%)

6,892.33 14.21 (0.21%)

50,440.45 -587.97 (-1.15%)

9,667.01 -43.86 (-0.45%)

89.99 -0.14 (-0.16%)

104.92 -0.11 (-0.11%)

120.05 0.29 (0.24%)

0.58 0.00 (0.11%)